Intrinsic Clinical Systems
- Company typePrivate
- Founded2014
- HeadquartersCollegeville, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
Intrinsic Clinical Systems firmographics
Firmographics- Name
- Intrinsic Clinical Systems
- Legal name
- Intrinsic Clinical Systems
- Website
- https://intrinsiccs.com
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Intrinsic Clinical Systems industry classification
Industry- Product category
- Clinical Trial Management Software
- NAICS
- Computer Systems Design Services (541512)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Clinical Trial Management Systems (CTMS) (HLACAOAD)
- akta.pro secondary industries
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI)
Keywords
Where Intrinsic Clinical Systems is headquartered
LocationHeadquarters
- HQ city
- Collegeville
- HQ country
- United States
- HQ region
- North America
Markets served
Intrinsic Clinical Systems business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- SaaS Software Subscriptions: Intrinsic Clinical Systems operates on a SaaS (Software as a Service) subscription model. Products including CTMS, Insights RM, Informer, and BioPhy are provided as cloud-based solutions with monthly SaaS fees. Updates to new standard versions are included in the monthly fee at no additional cost, with no vendor dependencies.
- Professional Services: Expert technical services offered alongside software products, including data integration, dynamic report building, validation, and other specialized technical consulting to help companies tackle challenges in clinical operations.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Enterprise SaaS subscription with monthly billing |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
Intrinsic Clinical Systems product offering
Product offeringCore offering
Intrinsic Clinical Systems sells a cloud-based SaaS platform for managing clinical trials, including Intrinsic CTMS for study startup, execution, and closeout; Insights RM for resource planning and scenario modeling; Informer for investigator feasibility and relationship management; Professional Services for implementation, integration, and validation; and Intrinsic BioPhy, an AI-powered regulatory research and QMS gap analysis suite acquired in February 2026. Products are delivered as monthly SaaS subscriptions to pharmaceutical companies and CROs worldwide.
Product overview
Intrinsic Clinical Systems offers a unified cloud-based clinical trial management platform comprising five integrated products: Insights RM for clinical resource management and forecasting, CTMS for comprehensive clinical trial operations and compliance, Informer for investigator relationship management and site feasibility, Professional Services for technical implementation support, and the acquired BioPhy brand for AI-powered regulatory intelligence and quality compliance. The platform emphasizes easy implementation (weeks not years), cloud-based SaaS delivery, and integration with existing clinical systems. BioPhy, acquired in February 2026, extends the platform's capabilities with regulatory research and quality analytics powered by hybrid AI engines.
Differentiator
Problem solved
Functional benefit
Brands
- Intrinsic BioPhy: AI solutions that transform operations for regulatory, quality, and operations teams, including regulatory research engine and QMS gap analysis solutions.
Products and services
- Intrinsic CTMS
Quantifiable outcome
- Manual quality review reduced by 85% through BioPhy's AI-driven SOP and regulatory alignment
- +2 more outcomes
Companies that use Intrinsic Clinical Systems
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles2 records
Intrinsic Clinical Systems technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration6 records
AI capability5 records
Feature6 records
Intrinsic Clinical Systems partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- BioPhycoreIntrinsic Clinical Systems acquired BioPhy, an enterprise AI company specializing in regulatory intelligence and quality system modernization for life sciences organizations. The transaction integrates BioPhy's regulatory research engine and QMS gap analysis solutions into Intrinsic's platform immediately upon closing. This acquisition extends Intrinsic's capabilities in AI-driven regulatory research and quality analytics for life sciences clients, positioning BioPhy's solutions as a core product line under the 'Intrinsic BioPhy' brand.
Scale indicators4 records
Recent moves5 records
Expansion highlights6 records
Intrinsic Clinical Systems competitors and assessment
Company assessmentBroad incumbents
- Veeva Systems: Veeva's Vault CTMS is one of the most widely deployed clinical trial management platforms globally, used by both large pharma sponsors and CROs. Veeva competes with Intrinsic in the same CTMS category but at significantly greater scale, broader product breadth (Vault CDB, eTMF, EDC), and deeper enterprise footprint.
- Medidata (Dassault Systèmes):
- Oracle (Clinical One / Siebel CTMS): Oracle's Clinical One platform and the legacy Siebel CTMS serve large pharmaceutical sponsors and CROs with end-to-end clinical operations capabilities. Oracle competes directly with Intrinsic in the CTMS category and bundles it with broader EDC, eTMF, and analytics offerings.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Intrinsic Clinical Systems social profiles
Digital presenceIntrinsic Clinical Systems compliance and trust
Trust signalCompliance3 records
Intrinsic Clinical Systems financial estimates
Financial estimateRevenue estimate
Valuation estimate
Intrinsic Clinical Systems leadership team
Management profileNumber of profiles
Profiles4 records
Intrinsic Clinical Systems subsidiaries and ownership
Company hierarchySubsidiaries1 record
Intrinsic Clinical Systems funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Intrinsic Clinical Systems M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Intrinsic Clinical Systems
What does Intrinsic Clinical Systems do?
Intrinsic Clinical Systems sells a cloud-based SaaS platform for managing clinical trials, including Intrinsic CTMS for study startup, execution, and closeout; Insights RM for resource planning and scenario modeling; Informer for investigator feasibility and relationship management; Professional Services for implementation, integration, and validation; and Intrinsic BioPhy, an AI-powered regulatory research and QMS gap analysis suite acquired in February 2026. Products are delivered as monthly SaaS subscriptions to pharmaceutical companies and CROs worldwide.
Is Intrinsic Clinical Systems a public or private company?
Intrinsic Clinical Systems is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Intrinsic Clinical Systems founded?
Intrinsic Clinical Systems was founded in 2014. It employs 1 to 10 people.
Where is Intrinsic Clinical Systems based?
Intrinsic Clinical Systems is headquartered in Collegeville, United States, in the North America region.
How does Intrinsic Clinical Systems make money?
Two revenue lines are on record. SaaS Software Subscriptions are the primary driver. The others are professional Services.
Who are Intrinsic Clinical Systems's main competitors?
Broad incumbents on record are Veeva Systems, Medidata (Dassault Systèmes) and Oracle (Clinical One / Siebel CTMS).
Does Intrinsic Clinical Systems have an API?
No public API is recorded for Intrinsic Clinical Systems.
What industry is Intrinsic Clinical Systems in?
Intrinsic Clinical Systems's product category is Clinical Trial Management Software. Its primary akta.pro industry code is HLACAOAD, Clinical Trial Management Systems (CTMS), with a secondary code of HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF). Its NAICS code is 541512 and its SIC code is 7372.